L., Raghuram, V
Stereoselective product inhibition of glutathione S-transferase [PMID: 3814126] Laboratory literature summary: Stereoselective product inhibition of glutathione S-transferase
(1997, N=22) demonstrated that nightly subcutaneous sermorelin increased mean IGF-1 by approximately 30% over 6 months in healthy men aged 60-75, with improvements in sleep architecture as a secondary finding
Read full referral policy No dosing claims No human-use language No before/after images No disease, fat-loss, injury, recovery, or anti-aging claims No "how to use" content No coded, indirect, or wink-wink language implying human or veterinary use Violations terminate referral access COA Workflow Certificates of Analysis COA documents are matched to released product lots
Well review potential interactions, assess synergistic opportunities, and design an integrated protocol that maximizes cognitive enhancement while maintaining safety
To validate this mechanism, we conducted in in vivo and in vitro experiments